Aberrant activation of the PI3K/AKT signaling pathway facilitates a variety of cellular activities such as proliferation, cell cycle progression, aggressiveness, and chemoresistance in many cancers, especially in CRC37. This evidence concerns the gene AKT1 and cancer.